Quavonlimab
Product Specifications
UNSPSC Description
Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody[1].
Target Antigen
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/quavonlimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Quavonlimab]
References & Citations
[1]Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32(3):395-403.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99809/Quavonlimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99809/Quavonlimab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2254059-25-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human Monoclonal CCR5 Antibody (leronlimab) [CoraFluor 1]](https://cdn.genprice.uk/genprice/genprice2.png)
AE23937MO-01 48 Tests
Mouse Pituitary adenylate cyclase-activating polypeptide type I receptor (ADCYAP1R1) ELISA Kit
Ask
View Details AE23937MO-02 96 Tests
Mouse Pituitary adenylate cyclase-activating polypeptide type I receptor (ADCYAP1R1) ELISA Kit
Ask
View Details ![Mouse Monoclonal CD163L1 Antibody (CD163L1/7972) [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/genprice5.png)
NBP3-24185JF549 0.1 mL
Mouse Monoclonal CD163L1 Antibody (CD163L1/7972) [Janelia Fluor 549]
Ask
View Details